Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by DiagnaMed Holdings Corp.
DiagnaMed Expands with Drug and Clinical Research AI Platform
August 21, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
August 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces LIFE Offering of up to $650,000
May 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
May 15, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper
April 25, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
April 23, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI
April 03, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces BRAIN AGE® Trademark Registration Approved by CIPO
March 20, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Strengthening Intellectual Property Support for CERVAI™ Brain Health AI Solution
March 14, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Accelerates Commercialization Initiatives of CERVAI™ Brain Health AI Solution
March 11, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces Test Launch of CERVAI™ Brain Health in University Brain Health Center
February 28, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces Pilot Launch of CERVAI™ Brain Health AI Solution
January 17, 2024
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Accelerates Commercialization of CERVAI™ Brain Health AI Platform with Acceptance into the SOPHIE Program
November 15, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
October 03, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Provides Update for its Brain Health AI Platform, CERVAI™
September 13, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Provides Update on CERVAI™, a Brain Health AI Platform Leveraging Generative AI
June 20, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Launches PalGPT.ai, a Generative AI Brain Health Solution
May 25, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Announces DTC Eligibility of Its Common Shares in the United States
May 17, 2023
From
DiagnaMed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Launches “Health GenAI”, a New Division for Generative AI Healthcare Solutions
May 10, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Launches FormGPT.io, a Generative AI Healthcare Solution
May 03, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DGNMF
DiagnaMed Enters into License Agreement with University of Miami for Brain Health Platform for Integration with CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 22, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DiagnaMed Prioritizes Development and Commercialization Initiatives for CERVAI™, a Brain Health AI Platform Leveraging Generative AI
February 14, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DiagnaMed Holdings Incorporates OpenAI’s ChatGPT into BRAIN AGE™ AI Product Suite
February 01, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DiagnaMed Holdings Provides Update for BRAIN AGE™ Development and Commercialization Milestones for 2023
January 31, 2023
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
DiagnaMed Holdings Acquires Exclusive Rights to a Virtual Reality and Artificial Intelligence-based Neurodiagnostic System for Neurodegenerative Disease
November 15, 2022
From
Diagnamed Holdings Corp.
Via
GlobeNewswire
Tickers
CSE:DMED
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.